Indicated for: breast cancer
Route of administration: oral
Substance: letrozole (aromatase inhibitor)
ATC: L02BG04 (Antineoplastic and immunomodulating agents | Hormone antagonists and related agents | Aromatase inhibitors)
Letrozole is an aromatase inhibitor used for the treatment of hormone-dependent breast cancer in postmenopausal women. It works by reducing estrogen levels, thereby inhibiting the growth of hormone-sensitive tumors.
The medication is taken orally, usually once daily, as directed by a doctor. It is important to follow the treatment regimen to achieve the best results.
Side effects may include hot flashes, fatigue, joint pain, or osteoporosis. In rare cases, allergic reactions or liver disorders may occur.
Letrozole is not recommended for pregnant or breastfeeding women or patients with hypersensitivity to this medication.